Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Transdermal Patch Drug Delivery System Revenue 1.4 Market Analysis by Type 1.4.1 Global Transdermal Patch Drug Delivery System Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Shunt Way 1.4.3 Intercellular Lipid Structure Pathway 1.4.4 Trans-cellular Pathway 1.5 Market by Application 1.5.1 Global Transdermal Patch Drug Delivery System Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Home Care 1.5.5 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Transdermal Patch Drug Delivery System Market Perspective (2015-2026) 2.2 Transdermal Patch Drug Delivery System Growth Trends by Regions 2.2.1 Transdermal Patch Drug Delivery System Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Transdermal Patch Drug Delivery System Historic Market Share by Regions (2015-2020) 2.2.3 Transdermal Patch Drug Delivery System Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Transdermal Patch Drug Delivery System Market Growth Strategy 2.3.6 Primary Interviews with Key Transdermal Patch Drug Delivery System Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Transdermal Patch Drug Delivery System Players by Market Size 3.1.1 Global Top Transdermal Patch Drug Delivery System Players by Revenue (2015-2020) 3.1.2 Global Transdermal Patch Drug Delivery System Revenue Market Share by Players (2015-2020) 3.1.3 Global Transdermal Patch Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Transdermal Patch Drug Delivery System Market Concentration Ratio 3.2.1 Global Transdermal Patch Drug Delivery System Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Transdermal Patch Drug Delivery System Revenue in 2019 3.3 Transdermal Patch Drug Delivery System Key Players Head office and Area Served 3.4 Key Players Transdermal Patch Drug Delivery System Product Solution and Service 3.5 Date of Enter into Transdermal Patch Drug Delivery System Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Transdermal Patch Drug Delivery System Historic Market Size by Type (2015-2020) 4.2 Global Transdermal Patch Drug Delivery System Forecasted Market Size by Type (2021-2026) 5 Transdermal Patch Drug Delivery System Breakdown Data by Application (2015-2026) 5.1 Global Transdermal Patch Drug Delivery System Market Size by Application (2015-2020) 5.2 Global Transdermal Patch Drug Delivery System Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Transdermal Patch Drug Delivery System Market Size (2015-2020) 6.2 Transdermal Patch Drug Delivery System Key Players in North America (2019-2020) 6.3 North America Transdermal Patch Drug Delivery System Market Size by Type (2015-2020) 6.4 North America Transdermal Patch Drug Delivery System Market Size by Application (2015-2020) 7 Europe 7.1 Europe Transdermal Patch Drug Delivery System Market Size (2015-2020) 7.2 Transdermal Patch Drug Delivery System Key Players in Europe (2019-2020) 7.3 Europe Transdermal Patch Drug Delivery System Market Size by Type (2015-2020) 7.4 Europe Transdermal Patch Drug Delivery System Market Size by Application (2015-2020) 8 China 8.1 China Transdermal Patch Drug Delivery System Market Size (2015-2020) 8.2 Transdermal Patch Drug Delivery System Key Players in China (2019-2020) 8.3 China Transdermal Patch Drug Delivery System Market Size by Type (2015-2020) 8.4 China Transdermal Patch Drug Delivery System Market Size by Application (2015-2020) 9 Japan 9.1 Japan Transdermal Patch Drug Delivery System Market Size (2015-2020) 9.2 Transdermal Patch Drug Delivery System Key Players in Japan (2019-2020) 9.3 Japan Transdermal Patch Drug Delivery System Market Size by Type (2015-2020) 9.4 Japan Transdermal Patch Drug Delivery System Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Transdermal Patch Drug Delivery System Market Size (2015-2020) 10.2 Transdermal Patch Drug Delivery System Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Transdermal Patch Drug Delivery System Market Size by Type (2015-2020) 10.4 Southeast Asia Transdermal Patch Drug Delivery System Market Size by Application (2015-2020) 11 India 11.1 India Transdermal Patch Drug Delivery System Market Size (2015-2020) 11.2 Transdermal Patch Drug Delivery System Key Players in India (2019-2020) 11.3 India Transdermal Patch Drug Delivery System Market Size by Type (2015-2020) 11.4 India Transdermal Patch Drug Delivery System Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Transdermal Patch Drug Delivery System Market Size (2015-2020) 12.2 Transdermal Patch Drug Delivery System Key Players in Central & South America (2019-2020) 12.3 Central & South America Transdermal Patch Drug Delivery System Market Size by Type (2015-2020) 12.4 Central & South America Transdermal Patch Drug Delivery System Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Hisamitsu Pharmaceutical 13.1.1 Hisamitsu Pharmaceutical Company Details 13.1.2 Hisamitsu Pharmaceutical Business Overview and Its Total Revenue 13.1.3 Hisamitsu Pharmaceutical Transdermal Patch Drug Delivery System Introduction 13.1.4 Hisamitsu Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2015-2020)) 13.1.5 Hisamitsu Pharmaceutical Recent Development 13.2 Novartis 13.2.1 Novartis Company Details 13.2.2 Novartis Business Overview and Its Total Revenue 13.2.3 Novartis Transdermal Patch Drug Delivery System Introduction 13.2.4 Novartis Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 13.2.5 Novartis Recent Development 13.3 ProSolus 13.3.1 ProSolus Company Details 13.3.2 ProSolus Business Overview and Its Total Revenue 13.3.3 ProSolus Transdermal Patch Drug Delivery System Introduction 13.3.4 ProSolus Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 13.3.5 ProSolus Recent Development 13.4 Tapemark 13.4.1 Tapemark Company Details 13.4.2 Tapemark Business Overview and Its Total Revenue 13.4.3 Tapemark Transdermal Patch Drug Delivery System Introduction 13.4.4 Tapemark Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 13.4.5 Tapemark Recent Development 13.5 Tesa Labtec 13.5.1 Tesa Labtec Company Details 13.5.2 Tesa Labtec Business Overview and Its Total Revenue 13.5.3 Tesa Labtec Transdermal Patch Drug Delivery System Introduction 13.5.4 Tesa Labtec Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 13.5.5 Tesa Labtec Recent Development 13.6 NITTO DENKO CORPORATION 13.6.1 NITTO DENKO CORPORATION Company Details 13.6.2 NITTO DENKO CORPORATION Business Overview and Its Total Revenue 13.6.3 NITTO DENKO CORPORATION Transdermal Patch Drug Delivery System Introduction 13.6.4 NITTO DENKO CORPORATION Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 13.6.5 NITTO DENKO CORPORATION Recent Development 13.7 Noven Pharmaceuticals 13.7.1 Noven Pharmaceuticals Company Details 13.7.2 Noven Pharmaceuticals Business Overview and Its Total Revenue 13.7.3 Noven Pharmaceuticals Transdermal Patch Drug Delivery System Introduction 13.7.4 Noven Pharmaceuticals Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 13.7.5 Noven Pharmaceuticals Recent Development 13.8 LTS Lohmann Therapie-Systeme 13.8.1 LTS Lohmann Therapie-Systeme Company Details 13.8.2 LTS Lohmann Therapie-Systeme Business Overview and Its Total Revenue 13.8.3 LTS Lohmann Therapie-Systeme Transdermal Patch Drug Delivery System Introduction 13.8.4 LTS Lohmann Therapie-Systeme Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 13.8.5 LTS Lohmann Therapie-Systeme Recent Development 13.9 Medherant 13.9.1 Medherant Company Details 13.9.2 Medherant Business Overview and Its Total Revenue 13.9.3 Medherant Transdermal Patch Drug Delivery System Introduction 13.9.4 Medherant Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 13.9.5 Medherant Recent Development 13.10 Corium 13.10.1 Corium Company Details 13.10.2 Corium Business Overview and Its Total Revenue 13.10.3 Corium Transdermal Patch Drug Delivery System Introduction 13.10.4 Corium Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 13.10.5 Corium Recent Development 13.11 Antares Pharma 10.11.1 Antares Pharma Company Details 10.11.2 Antares Pharma Business Overview and Its Total Revenue 10.11.3 Antares Pharma Transdermal Patch Drug Delivery System Introduction 10.11.4 Antares Pharma Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 10.11.5 Antares Pharma Recent Development 13.12 Syntropharma 10.12.1 Syntropharma Company Details 10.12.2 Syntropharma Business Overview and Its Total Revenue 10.12.3 Syntropharma Transdermal Patch Drug Delivery System Introduction 10.12.4 Syntropharma Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 10.12.5 Syntropharma Recent Development 13.13 Teikoku Pharma 10.13.1 Teikoku Pharma Company Details 10.13.2 Teikoku Pharma Business Overview and Its Total Revenue 10.13.3 Teikoku Pharma Transdermal Patch Drug Delivery System Introduction 10.13.4 Teikoku Pharma Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 10.13.5 Teikoku Pharma Recent Development 13.14 Mylan 10.14.1 Mylan Company Details 10.14.2 Mylan Business Overview and Its Total Revenue 10.14.3 Mylan Transdermal Patch Drug Delivery System Introduction 10.14.4 Mylan Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 10.14.5 Mylan Recent Development 13.15 Actavis 10.15.1 Actavis Company Details 10.15.2 Actavis Business Overview and Its Total Revenue 10.15.3 Actavis Transdermal Patch Drug Delivery System Introduction 10.15.4 Actavis Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 10.15.5 Actavis Recent Development 13.16 Mundipharma 10.16.1 Mundipharma Company Details 10.16.2 Mundipharma Business Overview and Its Total Revenue 10.16.3 Mundipharma Transdermal Patch Drug Delivery System Introduction 10.16.4 Mundipharma Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 10.16.5 Mundipharma Recent Development 13.17 Henan Lingrui Pharmaceutical 10.17.1 Henan Lingrui Pharmaceutical Company Details 10.17.2 Henan Lingrui Pharmaceutical Business Overview and Its Total Revenue 10.17.3 Henan Lingrui Pharmaceutical Transdermal Patch Drug Delivery System Introduction 10.17.4 Henan Lingrui Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 10.17.5 Henan Lingrui Pharmaceutical Recent Development 13.18 Changzhou Siyao 10.18.1 Changzhou Siyao Company Details 10.18.2 Changzhou Siyao Business Overview and Its Total Revenue 10.18.3 Changzhou Siyao Transdermal Patch Drug Delivery System Introduction 10.18.4 Changzhou Siyao Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 10.18.5 Changzhou Siyao Recent Development 13.19 Rfl Pharmaceutical 10.19.1 Rfl Pharmaceutical Company Details 10.19.2 Rfl Pharmaceutical Business Overview and Its Total Revenue 10.19.3 Rfl Pharmaceutical Transdermal Patch Drug Delivery System Introduction 10.19.4 Rfl Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) 10.19.5 Rfl Pharmaceutical Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Transdermal Patch Drug Delivery System Key Market Segments Table 2. Key Players Covered: Ranking by Transdermal Patch Drug Delivery System Revenue Table 3. Ranking of Global Top Transdermal Patch Drug Delivery System Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Transdermal Patch Drug Delivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Shunt Way Table 6. Key Players of Intercellular Lipid Structure Pathway Table 7. Key Players of Trans-cellular Pathway Table 8. Global Transdermal Patch Drug Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Transdermal Patch Drug Delivery System Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Transdermal Patch Drug Delivery System Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Transdermal Patch Drug Delivery System Market Share by Regions (2015-2020) Table 12. Global Transdermal Patch Drug Delivery System Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Transdermal Patch Drug Delivery System Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Transdermal Patch Drug Delivery System Market Growth Strategy Table 18. Main Points Interviewed from Key Transdermal Patch Drug Delivery System Players Table 19. Global Transdermal Patch Drug Delivery System Revenue by Players (2015-2020) (Million US$) Table 20. Global Transdermal Patch Drug Delivery System Market Share by Players (2015-2020) Table 21. Global Top Transdermal Patch Drug Delivery System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Patch Drug Delivery System as of 2019) Table 22. Global Transdermal Patch Drug Delivery System by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Transdermal Patch Drug Delivery System Product Solution and Service Table 25. Date of Enter into Transdermal Patch Drug Delivery System Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Transdermal Patch Drug Delivery System Market Size by Type (2015-2020) (Million US$) Table 28. Global Transdermal Patch Drug Delivery System Market Size Share by Type (2015-2020) Table 29. Global Transdermal Patch Drug Delivery System Revenue Market Share by Type (2021-2026) Table 30. Global Transdermal Patch Drug Delivery System Market Size Share by Application (2015-2020) Table 31. Global Transdermal Patch Drug Delivery System Market Size by Application (2015-2020) (Million US$) Table 32. Global Transdermal Patch Drug Delivery System Market Size Share by Application (2021-2026) Table 33. North America Key Players Transdermal Patch Drug Delivery System Revenue (2019-2020) (Million US$) Table 34. North America Key Players Transdermal Patch Drug Delivery System Market Share (2019-2020) Table 35. North America Transdermal Patch Drug Delivery System Market Size by Type (2015-2020) (Million US$) Table 36. North America Transdermal Patch Drug Delivery System Market Share by Type (2015-2020) Table 37. North America Transdermal Patch Drug Delivery System Market Size by Application (2015-2020) (Million US$) Table 38. North America Transdermal Patch Drug Delivery System Market Share by Application (2015-2020) Table 39. Europe Key Players Transdermal Patch Drug Delivery System Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Transdermal Patch Drug Delivery System Market Share (2019-2020) Table 41. Europe Transdermal Patch Drug Delivery System Market Size by Type (2015-2020) (Million US$) Table 42. Europe Transdermal Patch Drug Delivery System Market Share by Type (2015-2020) Table 43. Europe Transdermal Patch Drug Delivery System Market Size by Application (2015-2020) (Million US$) Table 44. Europe Transdermal Patch Drug Delivery System Market Share by Application (2015-2020) Table 45. China Key Players Transdermal Patch Drug Delivery System Revenue (2019-2020) (Million US$) Table 46. China Key Players Transdermal Patch Drug Delivery System Market Share (2019-2020) Table 47. China Transdermal Patch Drug Delivery System Market Size by Type (2015-2020) (Million US$) Table 48. China Transdermal Patch Drug Delivery System Market Share by Type (2015-2020) Table 49. China Transdermal Patch Drug Delivery System Market Size by Application (2015-2020) (Million US$) Table 50. China Transdermal Patch Drug Delivery System Market Share by Application (2015-2020) Table 51. Japan Key Players Transdermal Patch Drug Delivery System Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Transdermal Patch Drug Delivery System Market Share (2019-2020) Table 53. Japan Transdermal Patch Drug Delivery System Market Size by Type (2015-2020) (Million US$) Table 54. Japan Transdermal Patch Drug Delivery System Market Share by Type (2015-2020) Table 55. Japan Transdermal Patch Drug Delivery System Market Size by Application (2015-2020) (Million US$) Table 56. Japan Transdermal Patch Drug Delivery System Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Transdermal Patch Drug Delivery System Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Transdermal Patch Drug Delivery System Market Share (2019-2020) Table 59. Southeast Asia Transdermal Patch Drug Delivery System Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Transdermal Patch Drug Delivery System Market Share by Type (2015-2020) Table 61. Southeast Asia Transdermal Patch Drug Delivery System Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Transdermal Patch Drug Delivery System Market Share by Application (2015-2020) Table 63. India Key Players Transdermal Patch Drug Delivery System Revenue (2019-2020) (Million US$) Table 64. India Key Players Transdermal Patch Drug Delivery System Market Share (2019-2020) Table 65. India Transdermal Patch Drug Delivery System Market Size by Type (2015-2020) (Million US$) Table 66. India Transdermal Patch Drug Delivery System Market Share by Type (2015-2020) Table 67. India Transdermal Patch Drug Delivery System Market Size by Application (2015-2020) (Million US$) Table 68. India Transdermal Patch Drug Delivery System Market Share by Application (2015-2020) Table 69. Central & South America Key Players Transdermal Patch Drug Delivery System Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Transdermal Patch Drug Delivery System Market Share (2019-2020) Table 71. Central & South America Transdermal Patch Drug Delivery System Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Transdermal Patch Drug Delivery System Market Share by Type (2015-2020) Table 73. Central & South America Transdermal Patch Drug Delivery System Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Transdermal Patch Drug Delivery System Market Share by Application (2015-2020) Table 75. Hisamitsu Pharmaceutical Company Details Table 76. Hisamitsu Pharmaceutical Business Overview Table 77. Hisamitsu Pharmaceutical Product Table 78. Hisamitsu Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 79. Hisamitsu Pharmaceutical Recent Development Table 80. Novartis Company Details Table 81. Novartis Business Overview Table 82. Novartis Product Table 83. Novartis Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 84. Novartis Recent Development Table 85. ProSolus Company Details Table 86. ProSolus Business Overview Table 87. ProSolus Product Table 88. ProSolus Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 89. ProSolus Recent Development Table 90. Tapemark Company Details Table 91. Tapemark Business Overview Table 92. Tapemark Product Table 93. Tapemark Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 94. Tapemark Recent Development Table 95. Tesa Labtec Company Details Table 96. Tesa Labtec Business Overview Table 97. Tesa Labtec Product Table 98. Tesa Labtec Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 99. Tesa Labtec Recent Development Table 100. NITTO DENKO CORPORATION Company Details Table 101. NITTO DENKO CORPORATION Business Overview Table 102. NITTO DENKO CORPORATION Product Table 103. NITTO DENKO CORPORATION Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 104. NITTO DENKO CORPORATION Recent Development Table 105. Noven Pharmaceuticals Company Details Table 106. Noven Pharmaceuticals Business Overview Table 107. Noven Pharmaceuticals Product Table 108. Noven Pharmaceuticals Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 109. Noven Pharmaceuticals Recent Development Table 110. LTS Lohmann Therapie-Systeme Business Overview Table 111. LTS Lohmann Therapie-Systeme Product Table 112. LTS Lohmann Therapie-Systeme Company Details Table 113. LTS Lohmann Therapie-Systeme Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 114. LTS Lohmann Therapie-Systeme Recent Development Table 115. Medherant Company Details Table 116. Medherant Business Overview Table 117. Medherant Product Table 118. Medherant Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 119. Medherant Recent Development Table 120. Corium Company Details Table 121. Corium Business Overview Table 122. Corium Product Table 123. Corium Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 124. Corium Recent Development Table 125. Antares Pharma Company Details Table 126. Antares Pharma Business Overview Table 127. Antares Pharma Product Table 128. Antares Pharma Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 129. Antares Pharma Recent Development Table 130. Syntropharma Company Details Table 131. Syntropharma Business Overview Table 132. Syntropharma Product Table 133. Syntropharma Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 134. Syntropharma Recent Development Table 135. Teikoku Pharma Company Details Table 136. Teikoku Pharma Business Overview Table 137. Teikoku Pharma Product Table 138. Teikoku Pharma Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 139. Teikoku Pharma Recent Development Table 140. Mylan Company Details Table 141. Mylan Business Overview Table 142. Mylan Product Table 143. Mylan Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 144. Mylan Recent Development Table 145. Actavis Company Details Table 146. Actavis Business Overview Table 147. Actavis Product Table 148. Actavis Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 149. Actavis Recent Development Table 150. Mundipharma Company Details Table 151. Mundipharma Business Overview Table 152. Mundipharma Product Table 153. Mundipharma Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 154. Mundipharma Recent Development Table 155. Henan Lingrui Pharmaceutical Company Details Table 156. Henan Lingrui Pharmaceutical Business Overview Table 157. Henan Lingrui Pharmaceutical Product Table 158. Henan Lingrui Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 159. Henan Lingrui Pharmaceutical Recent Development Table 160. Changzhou Siyao Company Details Table 161. Changzhou Siyao Business Overview Table 162. Changzhou Siyao Product Table 163. Changzhou Siyao Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 164. Changzhou Siyao Recent Development Table 165. Rfl Pharmaceutical Company Details Table 166. Rfl Pharmaceutical Business Overview Table 167. Rfl Pharmaceutical Product Table 168. Rfl Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2015-2020) (Million US$) Table 169. Rfl Pharmaceutical Recent Development Table 170. Research Programs/Design for This Report Table 171. Key Data Information from Secondary Sources Table 172. Key Data Information from Primary Sources List of Figures Figure 1. Global Transdermal Patch Drug Delivery System Market Share by Type: 2020 VS 2026 Figure 2. Shunt Way Features Figure 3. Intercellular Lipid Structure Pathway Features Figure 4. Trans-cellular Pathway Features Figure 5. Global Transdermal Patch Drug Delivery System Market Share by Application: 2020 VS 2026 Figure 6. Hospital Case Studies Figure 7. Clinic Case Studies Figure 8. Home Care Case Studies Figure 9. Other Case Studies Figure 10. Transdermal Patch Drug Delivery System Report Years Considered Figure 11. Global Transdermal Patch Drug Delivery System Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Transdermal Patch Drug Delivery System Market Share by Regions: 2020 VS 2026 Figure 13. Global Transdermal Patch Drug Delivery System Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Transdermal Patch Drug Delivery System Market Share by Players in 2019 Figure 16. Global Top Transdermal Patch Drug Delivery System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Patch Drug Delivery System as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Transdermal Patch Drug Delivery System Revenue in 2019 Figure 18. North America Transdermal Patch Drug Delivery System Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Transdermal Patch Drug Delivery System Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Transdermal Patch Drug Delivery System Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Transdermal Patch Drug Delivery System Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Transdermal Patch Drug Delivery System Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Transdermal Patch Drug Delivery System Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Transdermal Patch Drug Delivery System Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Hisamitsu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Hisamitsu Pharmaceutical Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 27. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Novartis Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 29. ProSolus Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. ProSolus Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 31. Tapemark Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Tapemark Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 33. Tesa Labtec Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Tesa Labtec Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 35. NITTO DENKO CORPORATION Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. NITTO DENKO CORPORATION Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 37. Noven Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Noven Pharmaceuticals Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 39. LTS Lohmann Therapie-Systeme Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. LTS Lohmann Therapie-Systeme Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 41. Medherant Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Medherant Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 43. Corium Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Corium Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 45. Antares Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Antares Pharma Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 47. Syntropharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Syntropharma Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 49. Teikoku Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Teikoku Pharma Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 51. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. Mylan Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 53. Actavis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 54. Actavis Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 55. Mundipharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 56. Mundipharma Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 57. Henan Lingrui Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 58. Henan Lingrui Pharmaceutical Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 59. Changzhou Siyao Total Revenue (US$ Million): 2019 Compared with 2018 Figure 60. Changzhou Siyao Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 61. Rfl Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 62. Rfl Pharmaceutical Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2015-2020) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

Hisamitsu Pharmaceutical Novartis ProSolus Tapemark Tesa Labtec NITTO DENKO CORPORATION Noven Pharmaceuticals LTS Lohmann Therapie-Systeme Medherant Corium Antares Pharma Syntropharma Teikoku Pharma Mylan Actavis Mundipharma Henan Lingrui Pharmaceutical Changzhou Siyao Rfl Pharmaceutical